Multiple arterial thromboses and hyperhomocysteinemia in a young patient with methylenetetrahydrofolate reductase C677T mutation [2];Hiperhomocisteinemia y trombosis arteriales múltiples en un paciente joven con la mutación de la metilentetrahidrofolato reductasa C677T [2]

Revista Clinica Espanola

Volumn 204, Issue 11, 2004, Pages 607-608

  Yebra Yebra, M ^a   Fernandez Miranda C ^a   Prieto Rodriguez S ^a   Asenjo, R Martín ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; ARTERY THROMBOSIS; CASE REPORT; CLINICAL FEATURE; ELECTROCARDIOGRAPHY; GENE MUTATION; HEMOGLOBIN DETERMINATION; HUMAN; HYPERHOMOCYSTEINEMIA; LABORATORY DIAGNOSIS; LETTER; MALE; RISK ASSESSMENT; RISK FACTOR;

EID: 9444259164     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13067376     Document Type: Letter

References (10)

1. Córdoba Porras A, Blanco Vaca F, González Sastre F. Hiperhomocisteinemia, un nuevo marcador de riesgo vascular: territorios vasculares afectados, papel en la patogénesis de la arteriosclerosis y la trombosis y tratamiento. Med Clin (Barc) 1997; 109:715-25.
2. Danesh J, Lewington S. Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies. J Cardiovasc Risk 1998;5:229-32.
3. Stern JM, Saver JL, Boldy RM, de Gregorio F. Homocysteine associated hypercoagulability and disseminated thrombosis-a case report. Angiology 1998;49:765-9.
4. Panzere C, Brieke A, Brauer B, Eggeman F, Becker HM, Dieterle P. Junge patientin mit multiplen arteriellen verschlussen. Med Kfin 1998;93:311-8.
5. Blanco-Vaca F, López N, Cuquet J, Mateo J. Patient presenting multiple consecutive venous and arterial thrombotic events despite intensive conventional treatment: response after normalization of plasma homocysteine and N-acetylcysteine therapy. J Intern Med 2003;254:397-400.
6. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325:1202-6.
7. Graham IM, Daly LE, Refsum HM, Robinson K, Brattström LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease. JAMA 1997; 277:1775-81.
8. Fernández-Miranda C, Aranda JL, Gómez González P, Díaz-Rubio P, Estenoz J, Gómez de la Cámara A. La hiperhomocisteinemia es frecuente en pacientes con enfermedad coronaria. Estudio de 202 enfermos. Med Clin (Barc) 1999;113:407-10.
9. Fernández-Miranda C, Aranda JL, Paz M, Núñez V, Gómez González P, Díaz-Rubio P, et al. Aterosclerosis subclínica de la arteria carótida en pacientes con enfermedad coronaria. Med Clin (Barc) 2001;116:441-5.
10. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001;344:1222-31.